Rivastigmine and acute hepatic failure Patient Reports February 12, 2012

Rivastigmine Side Effects Report #5799581-5
Rivastigmine side effect was reported by a Consumer or non-health professional from SPAIN on June 19, 2008. Female patient, 80 years of age, was diagnosed with dementia alzheimer's type and was treated with Rivastigmine. After drug was administered, patient experienced the following side effects: acute hepatic failure, hepatitis toxic. Rivastigmine dosage: 1.5 MG, Q12H. During the same period patient was treated with RIVASTIGMINE TARTRATE, FUROSEMIDE, TRANKIMAZIN, PANTOPRAZOLE, ENOXAPARIN. Patient recovered.